ANI PHARMACEUTICALS, INC Payments of Debt Issuance Costs
ANI PHARMACEUTICALS, INC (ANIP) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-02-27
- ANI PHARMACEUTICALS, INC payments of debt issuance costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC payments of debt issuance costs for the quarter ending 2024-12-31 was $1.98M.
- ANI PHARMACEUTICALS, INC payments of debt issuance costs for the quarter ending 2023-12-31 was $0.00.
- ANI PHARMACEUTICALS, INC payments of debt issuance costs for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC payments of debt issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- ANI PHARMACEUTICALS, INC payments of debt issuance costs for fiscal 2024 was $17.35M.
- ANI PHARMACEUTICALS, INC payments of debt issuance costs for fiscal 2023 was $0.00.
- ANI PHARMACEUTICALS, INC payments of debt issuance costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | |||
| 2024-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $17.35M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $15.38M 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-08 | |||
| 2021-12-31 | $13.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $13.83M derived: sum of 2 quarters · filed 2023-03-09 | $13.97M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $262.00K 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $141.00K 10-Q · filed 2022-08-08 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $0.00 derived: sum of 2 quarters · filed 2022-03-15 | $0.00 10-K · filed 2022-03-15 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $0.00 10-Q · filed 2021-11-01 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-06 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $0.00 derived: sum of 2 quarters · filed 2022-03-15 | $0.00 derived: sum of 3 quarters · filed 2022-03-15 | $0.00 10-K · filed 2022-03-15 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | $1.42M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | $1.42M derived: sum of 3 quarters · filed 2021-03-11 | $1.42M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $1.42M derived: sum of 2 quarters · filed 2021-03-11 | $1.42M derived: sum of 3 quarters · filed 2021-03-11 | $1.42M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.42M derived: sum of 2 quarters · filed 2021-03-11 | $1.42M derived: sum of 3 quarters · filed 2021-03-11 | $1.57M 10-K · filed 2021-03-11 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $153.00K 10-Q · filed 2019-11-06 | $2.89M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $153.00K 10-Q · filed 2019-08-07 | $2.89M derived: sum of 3 quarters · filed 2019-08-07 | $2.89M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $153.00K 10-Q · filed 2019-05-09 | $2.89M derived: sum of 2 quarters · filed 2019-05-09 | $2.89M derived: sum of 3 quarters · filed 2019-05-09 | $2.89M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.74M derived: sum of 2 quarters · filed 2018-11-06 | $2.74M derived: sum of 3 quarters · filed 2018-11-06 | $2.74M 10-K · filed 2018-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | $0.00 derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | $0.00 derived: sum of 3 quarters · filed 2018-08-07 | $0.00 derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | $0.00 derived: sum of 2 quarters · filed 2018-05-08 | $0.00 derived: sum of 3 quarters · filed 2018-05-08 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $294.00K 10-K · filed 2018-02-27 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $294.00K 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | $294.00K 10-Q · filed 2017-08-03 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-02 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $0.00 derived: sum of 2 quarters · filed 2014-02-28 | $0.00 10-K · filed 2014-02-28 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | ||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | |||
| 2012-12-31 | $252.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $252.00 derived: sum of 2 quarters · filed 2014-02-28 | $261.00K 10-K · filed 2014-02-28 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $260.75K 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $260.75K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |